/KRYS

Krystal Biotech Inc

KRYS

$347.00USD↑+0.42%+1.45 today

MARKET CAP

10.3B

P/E (TTM)

46.4x

FWD P/E

—

DAY RANGE

$347 – $354

52W RANGE

$137

$383

AI Summary

Stalk

StalkMedium

KRYS remains in a Stage 2 advancing structure with clear higher highs and higher lows confirming medium-term bullishness, but recent weakness has led to a healthy pullback into the 9EMA, 20EMA, and 50SMA support zone. Short-term timing is neutral as the pullback lacks visible acceptance, so execution is deferred until absorption and a clean bounce off key EMAs before initiating exposure.

↑Q1 net revenue $116.4M (+32% YoY; +9% sequential growth).
↑Gross margin 95% reflects efficient manufacturing processes.
↓Negative earnings yield suggests potential overvaluation risk.

Full analysis →

Buying

5

institutions

Selling

8

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.18 M	1.55 B	+240.98 K	+52.7%	0.02%
JH Janus Henderson Group Plc Q1 2026	BUY	533.32 K	137.76 M	+313.88 K	+154.4%	0.03%
WP Woodline Partners LP Q2 2026	SELL	150.62 K	55.98 M	+-150.62 K	-28.1%	0.17%
JC Jpmorgan Chase & Co Q2 2026	SELL	87.34 K	33.48 M	+-11.76 K	+36.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	59.68 K	22.18 M	+50.08 K	+794.5%	0.03%
BA Bridgewater Associates, LP Q2 2026	BUY	54.49 K	20.25 M	+8.12 K	+69.1%	0.08%
CA Citadel Advisors LLC Q2 2026	BUY	43.02 K	15.99 M	+10.90 K	+92.7%	0.00%
FA Fisher Asset Management, LLC Q2 2026	SELL	27.68 K	10.29 M	+-108.00	+43.3%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	SELL	16.42 K	6.10 M	+-3.59 K	+18.0%	0.28%
AC Aqr Capital Management LLC Q2 2026	SELL	14.00 K	5.20 M	+-112.00	+42.7%	0.00%
FC Farallon Capital Management LLC Q1 2026	SELL	1.00 K	258.32 K	+-1.00 K	-47.6%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	217.00	80.65 K	+-14.00	+35.2%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-4.12 K	-100.0%	0.00%